Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RT + Temozolomide vs RT + Nitrosourea in Anaplastic Astrocytoma
NCT00004259Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Jun 2000
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of temozolomide in anaplastic astrocytoma (AA), anaplastic oligoastrocytoma (AMOA), sponsored by NRG Oncology. Started Jun 2000; status: completed.
02
Drugs
temozolomide
03
Conditions
anaplastic astrocytoma (AA)anaplastic oligoastrocytoma (AMOA)
Beyond the preview
Go deeper on NCT00004259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004259.